Description

Operator of a drug development platform designed to accelerate the development of next-gen immunomodulatory therapies for rare and inflammatory diseases. The company's platform enhances the drug development cycle by applying artificial intelligence to multiple-mechanism-of-action protein targets and their natural platform capabilities, creating novel therapeutics at an unprecedented pace and advancing purpose-built therapies for the lives of patients in need, enabling clients to develop purpose-built therapy for the lives of patients in need.